High-Dose Atorvastatin Reduces Periodontal Inflammation: A Novel Pleiotropic Effect of Statins

详细信息    查看全文

• 作者：Sharath Subramanian ; Hamed Emami ; Esad Vucic ; Parman ; Singh ; Jayanthi Vijayakumar ; Kenneth M. Fifer ; Achilles Alon ; Sudha S. Shankar ; Michael Farkouh ; James H.F. Rudd ; Zahi A. Fayad ; Thomas E. Van Dyke ; Ahmed Tawakol
• 关键词：statins ; atherosclerosis ; imaging ; nuclear medicine ; inflammation
• 刊名：Journal of the American College of Cardiology
• 出版年：24 December, 2013
• 年：2013
• 卷：62
• 期：25
• 页码：2382-2391
• 全文大小：932 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferencesg="UTF-8"?>

Objectives

The purpose of this study was to test whether high-dose statin treatment would result in a reduction in periodontal inflammation as assessed by ¹⁸F-fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography (CT).

Background

Periodontal disease (PD) is an independent risk factor for atherosclerosis.

Methods

Eighty-three adults with risk factors or with established atherosclerosis and who were not taking high-dose statins were randomized to atorvastatin 80 mg vs. 10 mg in a multicenter, double-blind trial to evaluate the impact of atorvastatin on arterial inflammation. Subjects were evaluated using FDG-PET/CT at baseline and at 4 and 12 weeks. Arterial and periodontal tracer activity was assessed while blinded to treatment allocation, clinical characteristics, and temporal sequence. Periodontal bone loss (an index of PD severity) was evaluated using contrast-enhanced CT images while blinded to clinical and imaging data.

Results

Seventy-one subjects completed the study, and 59 provided periodontal images for analysis. At baseline, areas of severe PD had higher target-to-background ratio (TBR) compared with areas without severe PD (mean TBR: 3.83 [95% confidence interval (CI): 3.36 to 4.30] vs. 3.18 [95% CI: 2.91 to 3.44], p聽= 0.004). After 12 weeks, there was a significant reduction in periodontal inflammation in patients randomized to atorvastatin 80 mg vs. 10 mg (螖TBR 80 mg vs. 10 mg group: mean聽鈭?.43 [95% CI:聽鈭?.83 to聽鈭?.02], p聽= 0.04). Between-group differences were greater in patients with higher periodontal inflammation at baseline (mean聽鈭?.74 [95% CI:聽鈭?.29 to聽鈭?.19], p聽= 0.01) and in patients with severe bone loss at baseline (鈭?.61 [95% CI:聽鈭?.16 to聽鈭?.054], p聽= 0.03). Furthermore, the changes in periodontal inflammation correlated with changes in carotid inflammation (R聽= 0.61, p聽< 0.001).

Conclusions

High-dose atorvastatin reduces periodontal inflammation, suggesting a newly recognized effect of statins. Given the concomitant changes observed in periodontal and arterial inflammation, these data raise the possibility that a portion of that beneficial impact of statins on atherosclerosis relate to reductions in extra-arterial inflammation, for example, periodontitis. (Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque; )